Form 4: Astronics Executive Exercises Stock Options
Insider Transaction Report
Mark Peabody, Executive VP & Pres-Aerospace at Astronics Corp., exercised stock options to acquire 5,951 shares of common and Class B stock.
Summary
- Mark Peabody, Executive VP & Pres-Aerospace of Astronics Corp. (ATRO), exercised stock options on November 19, 2025.
- Acquired 4,500 shares of $.01 PV Com Stk at an exercise price of $27.72 per share.
- Acquired 1,451 shares of $.01 PV CL B STK at an exercise price of $27.72 per share.
- Following these transactions, Mr. Peabody directly beneficially owns 55,324.73 shares of $.01 PV Com Stk and 185,445 shares of $.01 PV CL B STK.
- The exercised options, originally granted on December 3, 2016, and expiring on December 3, 2025, are now fully exercised and no longer held as derivative securities.
- Mr. Peabody continues to hold various other stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates extending to December 2033.
- He also holds Restricted Stock Units (RSUs) with performance-based vesting tied to Astronics Corp.'s average annual adjusted EBITDA for future periods.
Sentiment
Score: 7
Explanation: The exercise of stock options by a key executive to acquire additional shares suggests management confidence in the company's future prospects and valuation. This increases insider ownership, which can be viewed favorably by investors.
Positives
- Increased direct ownership by a key executive, signaling confidence in the company's future prospects.
- The exercise of options indicates the stock price was above the exercise price of $27.72, suggesting value creation for the option holder.
Risks
- Vesting of 15,900 Restricted Stock Units (RSUs) is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024, to December 31, 2026, with vesting ranging from 50% to 150% of the target number.
- Vesting of 10,850 Restricted Stock Units (RSUs) is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2023, to December 31, 2025, with vesting ranging from 75% to 115% of the target number.
- Vesting of 15,150 Restricted Stock Units (RSUs) is contingent on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025, to December 31, 2027, with vesting ranging from 50% to 150% of the target number.
Future Outlook
The company's future performance, specifically its average annual adjusted EBITDA, will determine the vesting percentage of a significant portion of executive Restricted Stock Units, indicating a focus on profitability and operational efficiency for executive incentives through 2027.
Industry Context
This filing is a standard insider transaction report and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with shareholder value through higher direct stock ownership. The performance-based RSU vesting ties executive compensation directly to the company's financial performance (EBITDA).
Next Steps
- Future vesting of Restricted Stock Units based on Astronics Corp.'s average annual adjusted EBITDA performance for the periods ending December 31, 2025, December 31, 2026, and December 31, 2027.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Grant date for options exercised on 11/19/2025. |
| 12/14/2017 | Date exercisable for certain stock options. |
| 12/12/2018 | Date exercisable for certain stock options. |
| 12/13/2019 | Date exercisable for certain stock options. |
| 12/09/2020 | Date exercisable for certain stock options. |
| 01/22/2022 | Date exercisable for certain stock options. |
| 12/09/2022 | Date exercisable for certain stock options. |
| 12/16/2023 | Date exercisable for certain stock options. |
| 01/01/2023 | Start of performance period for 10,850 Restricted Stock Units. |
| 12/07/2024 | Date exercisable for certain stock options. |
| 01/01/2024 | Start of performance period for 15,900 Restricted Stock Units. |
| 01/01/2025 | Start of performance period for 15,150 Restricted Stock Units. |
| 11/19/2025 | Transaction date for stock option exercise. |
| 12/03/2025 | Expiration date for options exercised on 11/19/2025. |
| 12/31/2025 | End of performance period for 10,850 Restricted Stock Units. |
| 02/23/2026 | Vesting date for 10,850 Restricted Stock Units. |
| 12/14/2026 | Expiration date for certain stock options. |
| 12/31/2026 | End of performance period for 15,900 Restricted Stock Units. |
| 02/22/2027 | Vesting date for 15,900 Restricted Stock Units. |
| 12/12/2027 | Expiration date for certain stock options. |
| 12/31/2027 | End of performance period for 15,150 Restricted Stock Units. |
| 02/27/2028 | Vesting date for 15,150 Restricted Stock Units. |
| 12/13/2028 | Expiration date for certain stock options. |
| 12/09/2029 | Expiration date for certain stock options. |
| 01/22/2031 | Expiration date for certain stock options. |
| 12/09/2031 | Expiration date for certain stock options. |
| 12/16/2032 | Expiration date for certain stock options. |
| 12/07/2033 | Expiration date for certain stock options. |
Keywords
Astronics Corp, ATRO, Mark Peabody, insider transaction, Form 4, stock options, common stock, Class B stock, executive compensation, beneficial ownership, restricted stock units, EBITDA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.